P glycoprotein (P-gp) and drug resistance – time for reappraisal?
نویسندگان
چکیده
منابع مشابه
P-Glycoprotein and Drug Resistance in Systemic Autoimmune Diseases
Autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are chronic inflammatory disorders of unknown etiology characterized by a wide range of abnormalities of the immune system that may compromise the function of several organs, such as kidney, heart, joints, brain and skin. Corticosteroids (CCS), synthetic and biologic immunosup...
متن کاملQuantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice.
The objective of this study was to quantitatively examine the protein expression of relevant transporters and other proteins in the brain capillary endothelial cells isolated from wild-type mice and P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice. After the isolation of brain capillary endothelial cells, a highly sensitive liquid chromatography-tandem...
متن کاملOvercoming P-glycoprotein-Mediated Drug Resistance in Epilepsy
2. ABSTRACT More than 20 million epileptics worldwide do not respond to antiepileptic drugs. This is in part due to overexpression of the drug efflux transporter, P-glycoprotein, in capillaries of the blood-brain barrier. However, the mechanism signaling P-glycoprotein upregulation is unknown. Lack of this knowledge is an important clinical problem, because it limits successful treatment of pat...
متن کاملP-glycoprotein Inhibition for Optimal Drug Delivery
P-glycoprotein (P-gp), an efflux membrane transporter, is widely distributed throughout the body and is responsible for limiting cellular uptake and the distribution of xenobiotics and toxic substances. Hundreds of structurally diverse therapeutic agents are substrates to it and it impedes the absorption, permeability, and retention of the drugs, extruding them out of the cells. It is overexpre...
متن کاملNatural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.
Multidrug resistance (MDR) is regarded as one of the bottlenecks of successful clinical treatment for numerous chemotherapeutic agents. Multiple key regulators are alleged to be responsible for MDR and making the treatment regimens ineffective. In this review, we discuss MDR in relation to P-glycoprotein (P-gp) and its down-regulation by natural bioactive molecules. P-gp, a unique ATP-dependent...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Cancer
سال: 1993
ISSN: 0007-0920,1532-1827
DOI: 10.1038/bjc.1993.119